SEARCH

Current Edition

bamlanivimab

Lilly drug becomes first COVID antibody cleared for use in young children

When bamlanivimab gained initial authorization 13 months ago, it was the first drug specifically designed to arrest infections of the SARS-CoV-2 virus that causes COVID-19. …

Continue Reading →